Background In the context of the COVID-19 worldwide pandemic, an up-to-date review of
current challenges in addictions is necessary. While large scale disasters may have an …

COVID-19, the global threat to humanity, shares etiological cofactors with multiple diseases
including Alzheimer's disease (AD). Understanding the common links between COVID-19 …

Numerous observational studies have attempted to identify risk factors for infection with
SARS-CoV-2 and COVID-19 disease outcomes. Studies have used datasets sampled from …

In December 2019, a novel severe acute respiratory syndrome (SARS) from a new
coronavirus (SARS-CoV-2) was recognized in the city of Wuhan, China. Rapidly, it became …

Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is a
newly recognized condition in children with recent severe acute respiratory syndrome …

Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

Aim To examine changes in smoking, drinking and quitting/reduction behaviour following
the COVID‐19 lockdown in England. Design/setting Monthly cross‐sectional surveys …

Background There is uncertainty about the associations of angiotensive enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied …

Multisystem inflammatory syndrome in children (MIS-C) is a febrile pediatric inflammatory
disease that may develop weeks after initial SARS-CoV-2 infection or exposure. MIS-C …

Background Identification of prognostic factors in COVID-19 remains a global challenge. The
role of smoking is still controversial. Objective To evaluate the rate of daily smokers in …